138 related articles for article (PubMed ID: 17642008)
21. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
[No Abstract] [Full Text] [Related]
22. Epothilone D (Kosan/Roche).
Kolman A
Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
[TBL] [Abstract][Full Text] [Related]
23. American Society of Clinical Oncology--41st annual meeting. Drug highlights I.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):531-3. PubMed ID: 15973555
[No Abstract] [Full Text] [Related]
24. Digestive Disease Week 2009. Turning science into medicine: Part 1.
Glah DR
IDrugs; 2009 Aug; 12(8):467-70. PubMed ID: 19629875
[No Abstract] [Full Text] [Related]
25. [Innovative drugs for the good of the patients].
Dietrich W
Krankenpfl J; 2005; 43(4-6):136. PubMed ID: 16171078
[No Abstract] [Full Text] [Related]
26. Sitafloxacin: DU 6859, DU 6859A, Gracevit, sitafloxacin hydrate.
Drugs R D; 2003; 4(1):61-8. PubMed ID: 12568642
[No Abstract] [Full Text] [Related]
27. 27th Annual JPMorgan Healthcare Conference--Ablynx and Facet Biotech.
Mason VL
IDrugs; 2009 Mar; 12(3):137-9. PubMed ID: 19333887
[No Abstract] [Full Text] [Related]
28. American society of clinical oncology--41st annual meeting.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):525-7. PubMed ID: 15973553
[No Abstract] [Full Text] [Related]
29. Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic.
Terrett NK
IDrugs; 2008 Mar; 11(3):164-8. PubMed ID: 18311648
[No Abstract] [Full Text] [Related]
30. OSI-461 (OSI).
Galmarini CM
Curr Opin Investig Drugs; 2004 Jun; 5(6):648-56. PubMed ID: 15242254
[TBL] [Abstract][Full Text] [Related]
31. Premarketing trials: too few patients.
Prescrire Int; 2014 Oct; 23(153):251. PubMed ID: 25964980
[No Abstract] [Full Text] [Related]
32. American Heart Association--Scientific Sessions 2007. Part 2.
Bright J
IDrugs; 2008 Jan; 11(1):19-20. PubMed ID: 18175255
[No Abstract] [Full Text] [Related]
33. Applied clinical trials--14th annual European summit.
Kirkham K
IDrugs; 2008 Jan; 11(1):21-4. PubMed ID: 18175256
[No Abstract] [Full Text] [Related]
34. SOP 08: Reporting of adverse events.
Onkologie; 2003 Oct; 26 Suppl 6():41-2. PubMed ID: 23570185
[No Abstract] [Full Text] [Related]
35. TLK-286.
Verschraegen CF; Smith HO; Lee FC; Cathcart C; Norenberg JP
IDrugs; 2004 Aug; 7(8):771-81. PubMed ID: 15334311
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic approaches for Alzheimer's disease.
Jahnke U
IDrugs; 2008 Jan; 11(1):4-6. PubMed ID: 18175250
[No Abstract] [Full Text] [Related]
37. Therapies targeting pain.
Jahnke U; McGee V
IDrugs; 2008 Jan; 11(1):13-5. PubMed ID: 18175253
[No Abstract] [Full Text] [Related]
38. Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients.
Abad CL; Razonable RR
Expert Rev Anti Infect Ther; 2017 Feb; 15(2):93-110. PubMed ID: 27911112
[TBL] [Abstract][Full Text] [Related]
39. Diflomotecan. Ipsen.
Osheroff N
IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
[No Abstract] [Full Text] [Related]
40. Inflammation 2003-Sixth World Congress. 2-6 August 2003, Vancouver, Canada.
Evans R
IDrugs; 2003 Sep; 6(9):831-3. PubMed ID: 14565165
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
